| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.30B | 2.21B | 2.20B | 2.05B | 1.87B |
| Gross Profit | 1.07B | 1.04B | 1.01B | 900.40M | 836.20M |
| EBITDA | 519.00M | 473.90M | 457.60M | 431.40M | 358.60M |
| Net Income | 309.90M | 248.50M | 237.30M | 226.30M | 196.30M |
Balance Sheet | |||||
| Total Assets | 2.48B | 2.49B | 2.47B | 2.52B | 2.17B |
| Cash, Cash Equivalents and Short-Term Investments | 114.90M | 150.00M | 108.20M | 135.00M | 97.50M |
| Total Debt | 643.70M | 695.50M | 745.10M | 945.00M | 717.40M |
| Total Liabilities | 1.37B | 1.41B | 1.44B | 1.61B | 1.39B |
| Stockholders Equity | 1.11B | 1.09B | 1.03B | 905.60M | 779.10M |
Cash Flow | |||||
| Free Cash Flow | 300.90M | 280.10M | 283.30M | 193.20M | 199.60M |
| Operating Cash Flow | 399.50M | 371.60M | 363.20M | 264.50M | 257.10M |
| Investing Cash Flow | -81.80M | -58.00M | -69.10M | -278.00M | -234.40M |
| Financing Cash Flow | -308.60M | -276.20M | -276.40M | 24.50M | -109.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £6.49B | 20.02 | 24.91% | 1.29% | -0.32% | -3.96% | |
71 Outperform | £987.51M | 15.43 | 33.12% | 1.01% | 24.42% | 103.25% | |
67 Neutral | £2.56B | 23.57 | 20.10% | 2.04% | 1.93% | -15.07% | |
64 Neutral | £7.14B | 15.58 | 13.46% | 1.93% | -6.93% | 18.57% | |
64 Neutral | £7.17B | 29.74 | 13.42% | 1.26% | -1.97% | 40.55% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | £4.94B | 30.76 | 13.86% | 2.46% | 0.10% | -15.33% |